UK-based CBD lifestyle brand TRIP has raised $12M to support the brand’s international growth. Investors in the round include prominent entrepreneurs, business leaders and investors, including Maria Raga, the former CEO of Depop, and Christian Angermayer, Founder of Apeiron Investment Group.
Known in the UK as the “Queen’s CBD,” having received the royal seal of approval by selling out of the Queen’s Windsor shop, TRIP was founded by husband-and-wife team Daniel Khoury and Olivia Ferdi after meeting at Cambridge University. The duo launched TRIP after a transformational personal experience with CBD when it helped Daniel recover from an accident that required knee surgery just before their wedding. Amazed by CBD’s benefits, the two left their careers in law and finance to launch TRIP together and designed a range of drinks, oils and gummies. Since the company’s launch in 2019, it has rapidly attracted a highly engaged online community and has been leading the market in the UK with 88% market share and distribution in over 11,000 retail locations.
TRIP Co-Founder Olivia Ferdi shares: “Over the last few years the world’s attitude towards the importance of mental health has changed dramatically. Since discovering the power of CBD through an incredible personal experience, our mission has always been to share calm in the everyday chaos, with next-generation wellbeing products to power your lifestyle and help care for your mental health. Helping to open up conversations around stress and anxiety, we’re excited to create a community across the globe, harnessing the power of plants to find their calm.”
Amidst a growing global mental health crisis, TRIP is dedicated to building a brand that helps people worldwide. The company has already introduced millions of people to their first CBD experience and today represents a new, functional consumer category that did not exist previously, supporting everyday health, well-being and stress relief.